Breast cancer chemopreventive and chemotherapeutic effects of Camellia Sinensis (green tea)
An updated review
Keywords:
Camellia sinensis, chemopreventive, chemotherapeutic, catechins, PhytochemicalsAbstract
Introduction: Camellia sinensis belongs to the plant family of Theaceae , native to East Asia, the Indian Subcontinent and Southeast Asia, but naturalized in many parts of the world. The aim of this study was to overview its anti-breast cancer chemopreventive and chemotherapeutic effects. This review article is aimed to overview breast cancer chemopreventive and chemotherapeutic effects of Camellia sinensis (green tea).
Methods: This review article was carried out by searching studies in PubMed, Medline, Web of Science, and IranMedex databases. The initial search strategy identified around 108 references. In this study, 68 studies were accepted for further screening, and met all our inclusion criteria [in English, full text, chemopreventive and chemotherapeutic effects of Camellia sinensis and dated mainly from the year 1999 to 2016. The search terms were Camellia sinensis, chemopreventive, chemotherapeutic properties, pharmacological effects.
Result: The result of this study suggested that the catechin available in Camellia sinensis has properties which can prevent and treat breast cancer. It has also been shown to inhibit proliferation of breast cancer cells and to block carcinogenesis. It was found that increased Camellia sinensis consumption may lower the risk of breast cancer. Camellia sinensis intake was shown to reduce the risk of breast cancer incidence. In addition, potential breast cancer chemopreventive effect of Camellia sinensis both in vivo and in vitro was highly confirmed. However, the evidence of low effect and no effect was observed. More clinical trial studies are needed to prove its anti-breast cancer activity decisively.
Conclusion: Camellia sinensis is broadly utilized as a part of customary medication since antiquated time because of its cost adequacy, and fewer reaction properties. The studies demonstrated anti-breast cancer activity of Camellia sinensis and its component by adjusting cell signaling pathways such as angiogenesis, apoptosis, and transcription factor. Furthermore, Camellia sinensis and its chemical compound was shown to be extremely useful in the development of novel anticancer medications.
References
Nasri H, Hajian S, Ahmadi A, Baradaran A, Kohi G, Nasri P, et al. Ameliorative effect of green tea against
contrast-induced renal tubular cell injury. Iran J Kidney Dis. 2015; 9(6): 421-6. PMID: 26552347.
Bahmani M, Sarrafchi A, Shirzad H, Rafieian-Kopaei M. Autism: Pathophysiology and Promising Herbal
Remedies. Current pharmaceutical design. 2016; 22(3): 277-85. doi:
2174/1381612822666151112151529. PMID: 26561063.
Nasri H, Rafieian-Kopaei M. Comment on: The effects of green tea consumption on metabolic and
anthropometric indices in patients with type 2 diabetes. J Res Med Sci. 2014; 19(12): 1203-4. PMID:
, PMCID: PMC4333532.
Nasri H, Ahmadi A, Baradaran A, Nasri P, Hajian S, Pour-Arian A, et al. A biochemical study on
ameliorative effect of green tea (Camellia sinensis) extract against contrast media induced acute kidney
injury. Journal of renal injury prevention. 2014; 3(2): 47-9. doi: 10.12861/jrip.2014.16. PMID: 25340167,
PMCID: PMC4206045.
Rafieian-Kopaei M, Saki K, Bahmani M, Ghafourian S, Sadeghifard N, Taherikalani M. Listeriosis
Phytotherapy: A Review Study on the Effectiveness of Iranian Medicinal Plants in Treatment of Listeriosis.
J Evid Based Complementary Altern Med. 2015. doi: 10.1177/2156587215621460.
Shaygannia E, Bahmani M, Zamanzad B, Rafieian-Kopaei M. A Review Study on Punica granatum L. J
Evid Based Complementary Altern Med. 2016; 21(3): 221-7. doi: 10.1177/2156587215598039. PMID:
Miraj S, Rafieian K, Kiani S. Melissa officinalis L: A Review Study With an Antioxidant Prospective.
Journal of evidence-based complementary & alternative medicine. 2016. doi: 10.1177/2156587216663433.
Baharvand-Ahmadi B, Bahmani M, Tajeddini P, Rafieian-Kopaei M, Naghdi N. An ethnobotanical study
of medicinal plants administered for the treatment of hypertension. J Renal Inj Prev. 2016; 5(3): 123-8. doi:
15171/jrip.2016.26. PMID: 27689107, PMCID: PMC5039997.
Mesripour A, Rafieian-Kopaei M, Bahrami B. The effects of Anethum graveolens essence on scopolamineinduced memory impairment in mice. Res Pharm Sci. 2016; 11(2): 145-51. PMID: 27168754, PMCID:
PMC4852659.
Asgharzade S, Rafieian-Kopaei M, Mirzaeian A, Reiisi S, Salimzadeh L. Aloe vera toxic effects:
expression of inducible nitric oxide synthase (iNOS) in testis of Wistar rat. Iran J Basic Med Sci. 2015;
(10): 967-73. PMID: 26730330, PMCID: PMC4686580.
Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. Oxidative stress and Parkinson's disease: New
hopes in treatment with herbal antioxidants. Current pharmaceutical design. 2016; 22(2): 238-46. doi:
2174/1381612822666151112151653.
Rouhi-Boroujeni H, Rouhi-Boroujeni H, Gharipour M, Mohammadizadeh F, Ahmadi S, Rafieian-Kopaei
M. Systematic review on safety and drug interaction of herbal therapy in hyperlipidemia: a guide for
internist. Acta Biomed. 2015; 86(2): 130-6. PMID: 26422426.
Nasri H, Ardalan MR, Rafieian-Kopaei M. Mechanistic Impacts of Medicinal Plants in Diabetic Kidney
Disease. Iran J Public Health. 2014; 43(9): 1311-3. PMID: 26175992, PMCID: PMC4500440.
Forester SC, Lambert JD. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in
cancer prevention. Mol Nutr Food Res. 2011; 55(6): 844-54. doi: 10.1002/mnfr.201000641. PMID:
, PMCID: PMC3679539.
Basu A, Betts NM, Mulugeta A, Tong C, Newman E, Lyons TJ. Green tea supplementation increases
glutathione and plasma antioxidant capacity in adults with the metabolic syndrome. Nutr Res. 2013; 33(3):
-7. doi: 10.1016/j.nutres.2012.12.010. PMID: 23507223, PMCID: PMC3603270.
Lambert JD, Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer
prevention. Arch Biochem Biophys. 2010; 501(1): 65-72. doi: 10.1016/j.abb.2010.06.013. PMID:
, PMCID: PMC2946098.
Parsaei P, Karimi M, Asadi SY, Rafieian-Kopaei M. Bioactive components and preventive effect of green
tea (Camellia sinensis) extract on post-laparotomy intra-abdominal adhesion in rats. Int J Surg. 2013; 11(9):
-5. doi: 10.1016/j.ijsu.2013.08.014. PMID: 23994005.
Sae-tan S, Grove KA, Lambert JD. Weight control and prevention of metabolic syndrome by green tea.
Pharmacol Res. 2011; 64(2): 146-54. doi: 10.1016/j.phrs.2010.12.013. PMID: 21193040, PMCID:
PMC3123415.
Hou IC, Amarnani S, Chong MT, Bishayee A. Green tea and the risk of gastric cancer: Epidemiological
evidence. World J Gastroenterol. 2013; 19(24): 3713-22. doi: 10.3748/wjg.v19.i24.3713. PMID: 23840110,
PMCID: PMC3699047.
Davalli P, Rizzi F, Caporali A, Pellacani D, Davoli S, Bettuzzi S, et al. Anticancer Activity of Green Tea
Polyphenols in Prostate Gland. Oxid Med Cell Longev. 2012; 2012: 984219. doi: 10.1155/2012/984219.
PMID: 22666523, PMCID: PMC3362217.
Asadi SY, Parsaei P, Karimi M, Ezzati S, Zamiri A, Mohammadizadeh F, et al. Effect of green tea
(Camellia sinensis) extract on healing process of surgical wounds in rat. Int J Surg. 2013; 11(4): 332-7. doi:
1016/j.ijsu.2013.02.014. PMID: 23459184.
Noguchi-Shinohara M, Yuki S, Dohmoto C, Ikeda Y, Samuraki M, Iwasa K, et al. Consumption of green
tea, but not black tea or coffee, is associated with reduced risk of cognitive decline. PLoS ONE. 2014; 9(5):
e96013. doi: 10.1371/journal.pone.0096013. PMID: 24828424, PMCID: PMC4020750.
Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an anti-oxidant and antiinflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets. 2007; 7(2):
-44. doi: 10.2174/187152907780830905. PMID: 17584048.
Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, et al. Prevention of collagen-induced
arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A. 1999; 96(8): 4524-9.
doi: 10.1073/pnas.96.8.4524. PMID: 10200295, PMCID: PMC16365.
Lin SP, Li CY, Suzuki K, Chang CK, Chou KM, Fang SH. Green Tea Consumption after Intense
Taekwondo Training Enhances Salivary Defense Factors and Antibacterial Capacity. PLoS ONE. 2014;
(1): e87580. doi: 10.1371/journal.pone.0087580. PMID: 24498143, PMCID: PMC3907556.
Stoicov C, Saffari R, Houghton J. Green tea inhibits Helicobacter growth in vivo and in vitro. Int J
Antimicrob Agents. 2009; 33(5): 473-8. doi: 10.1016/j.ijantimicag.2008.10.032. PMID: 19157800,
PMCID: PMC2694061.
Reygaert WC. The antimicrobial possibilities of green tea. Front Microbiol. 2014; 5: 434. doi:
3389/fmicb.2014.00434. PMID: 25191312, PMCID: PMC4138486.
Sartippour M, Shao Z, Heber D. Green tea inhibits vascular endothelial growth factor (VEGF) induction in
human breast cancer cells.(Abstracts). Alternative Medicine Review. 2002; 7(5): 429-30.
Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S. Inhibition of adenovirus infection and adenain
by green tea catechins. Antiviral Res. 2003; 58(2): 167-73. doi: 10.1016/S0166-3542(02)00212-7. PMID:
Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, et al. Cholesterol-lowering effect of a theaflavin- enriched green tea extract: a randomized controlled trial. Arch Intern Med. 2003; 163(12): 1448-53. doi:
1001/archinte.163.12.1448. PMID: 12824094.
Toolsee NA, Aruoma OI, Gunness TK, Kowlessur S, Dambala V, Murad F, et al. Effectiveness of Green
Tea in a Randomized Human Cohort: Relevance to Diabetes and Its Complications. Biomed Res Int. 2013;
: 412379. doi: 10.1155/2013/412379. PMID: 24102055, PMCID: PMC3786468.
Liu JB, Zhou L, Wang YZ, Wang X, Zhou Y, Ho WZ, et al. Neuroprotective Activity of (-)- Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity. J Immunol Res. 2016; 2016:
doi: 10.1155/2016/4962351. PMID: 27191001, PMCID: PMC4844887.
Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, et al. A new function of green tea:
prevention of lifestyle-related diseases. Ann N Y Acad Sci. 2001; 928(1): 274-80. doi: 10.1111/j.1749- 6632.2001.tb05656.x. PMID: 11795518.
Kanwar J, Taskeen M, Mohammad I, Huo C, Chan TH, Dou QP. Recent advances on tea polyphenols.
Front Biosci (Elite Ed). 2012; 4: 111-31. doi: 10.2741/e363. PMID: 22201858, PMCID: PMC3303150.
Johnson JJ, Bailey HH, Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: a
translational perspective. Phytomedicine. 2010; 17(1): 3-13. doi: 10.1016/j.phymed.2009.09.011. PMID:
, PMCID: PMC2789276.
Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 1997;
(8): 693-704. doi: 10.1080/10408399709527797. PMID: 9447270.
Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions.
Crit Rev Food Sci Nutr. 2003; 43(1): 89-143. doi: 10.1080/10408690390826464. PMID: 12587987.
Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. The American journal
of clinical nutrition. 2000; 71(6 Suppl): 1698S-702S; discussion 703S-4S. PMID: 10837321.
Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, et al. Effects of a green tea extract,
Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor‐
negative breast cancer. J Hum Nutr Diet. 2015; 28(3): 272-82. doi: 10.1111/jhn.12229. PMID: 24646362,
PMCID: PMC4205214.
Luo KW, Ko CH, Yue GG, Lee JK, Li KK, Lee M, et al. Green tea (Camellia sinensis) extract inhibits both
the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. J Nutr Biochem. 2014;
(4): 395-403. doi: 10.1016/j.jnutbio.2013.11.013. PMID: 24561153.
Yuan JM. Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr. 2013;
(6 Suppl): 1676S-81S. doi: 10.3945/ajcn.113.058271. PMID: 24172305, PMCID: PMC3831544.
Li M, Tse LA, Chan WC, Kwok CH, Leung SL, Wu C, et al. Evaluation of breast cancer risk associated
with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong.
Cancer Epidemiol. 2016; 40: 73-8. doi: 10.1016/j.canep.2015.11.013. PMID: 26680603.
Samavat H, Dostal AM, Wang R, Bedell S, Emory TH, Ursin G, et al. The Minnesota Green Tea Trial
(MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer
risk: study rationale, design, methods, and participant characteristics. Cancer Causes Control. 2015; 26(10):
-19. doi: 10.1007/s10552-015-0632-2. PMID: 26206423, PMCID: PMC4567901.
Dostal AM, Samavat H, Bedell S, Torkelson C, Wang R, Swenson K, et al. The safety of green tea extract
supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea
Trial. Food Chem Toxicol. 2015; 83: 26-35. doi: 10.1016/j.fct.2015.05.019. PMID: 26051348, PMCID:
PMC4540665.
Seely D, Mills EJ, Wu P, Verma S, Guyatt GH. The effects of green tea consumption on incidence of breast
cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2005;
(2): 144-55. doi: 10.1177/1534735405276420. PMID: 15911927.
Oh JK, Sandin S, Ström P, Löf M, Adami HO, Weiderpass E. Prospective study of breast cancer in relation
to coffee, tea and caffeine in Sweden. Int J Cancer. 2015; 137(8): 1979-89. doi: 10.1002/ijc.29569. PMID:
Tyagi T, Treas JN, Mahalingaiah PK, Singh KP. Potentiation of growth inhibition and epigenetic
modulation by combination of green tea polyphenol and 5-aza-2′-deoxycytidine in human breast cancer
cells. Breast Cancer Res Treat. 2015; 149(3): 655-68. doi: 10.1007/s10549-015-3295-5. PMID: 25663548.
Bhoo-Pathy N, Peeters PH, Uiterwaal CS, Bueno-de-Mesquita HB, Bulgiba AM, Bech BH, et al. Coffee
and tea consumption and risk of pre-and postmenopausal breast cancer in the European Prospective
Investigation into Cancer and Nutrition (EPIC) cohort study. Breast Cancer Res. 2015; 17: 15. doi:
1186/s13058-015-0521-3. PMID: 25637171, PMCID: PMC4349221.
Yiannakopoulou EC. Interaction of Green Tea Catechins with Breast Cancer Endocrine Treatment: A
Systematic Review. Pharmacology. 2014; 94(5-6): 245-8. doi: 10.1159/000369170. PMID: 25471334.
Wang P, Wang B, Chung S, Wu Y, Henning SM, Vadgama JV. Increased chemopreventive effect by
combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells. RSC Adv.
; 4(66): 35242-50. doi: 10.1039/C4RA06616B. PMID: 25243063, PMCID: PMC4166488.
Li MJ, Yin YC, Wang J, Jiang YF. Green tea compounds in breast cancer prevention and treatment. World
J Clin Oncol. 2014; 5(3): 520-8. doi: 10.5306/wjco.v5.i3.520. PMID: 25114865, PMCID: PMC4127621.
Yu SS, Spicer DV, Hawes D, Tseng CC, Yang CS, Pike MC, et al. Biological effects of green tea capsule
supplementation in pre-surgery postmenopausal breast cancer patients. Front Oncol. 2013; 3: 298. doi:
3389/fonc.2013.00298. PMID: 24380073, PMCID: PMC3861892.
Iwasaki M, Mizusawa J, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, et al. Green tea consumption
and breast cancer risk in Japanese women: a case-control study. Nutr Cancer. 2014; 66(1): 57-67. doi:
1080/01635581.2014.847963. PMID: 24274352.
Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, Shimazu T, et al. Green tea drinking and
subsequent risk of breast cancer in a population to based cohort of Japanese women. Breast Cancer Res.
; 12(5): R88. doi: 10.1186/bcr2756. PMID: 22889409, PMCID: PMC3096981.
Fix LN, Shah M, Efferth T, Farwell MA, Zhang B. MicroRNA expression profile of MCF-7 human breast
cancer cells and the effect of green tea polyphenon-60. Cancer Genomics Proteomics. 2010; 7(5): 261-77.
PMID: 20952761.
Li Y, Yuan YY, Meeran SM, Tollefsbol TO. Synergistic epigenetic reactivation of estrogen receptor-α
(ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer
cells. Mol Cancer. 2010; 9: 274. doi: 10.1186/1476-4598-9-274. PMID: 20946668, PMCID: PMC2967543.
Stendell‐Hollis NR, Thomson CA, Thompson PA, Bea JW, Cussler EC, Hakim IA. Green tea improves
metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors.
J Hum Nutr Diet. 2010; 23(6): 590-600. doi: 10.1111/j.1365-277X.2010.01078.x. PMID: 20807303,
PMCID: PMC2966548.
Landis-Piwowar K, Chen D, Chan TH, Dou QP. Inhibition of catechol-O-methyltransferase activity in
human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG. Oncol Rep.
; 24(2): 563-9. PMID: 20596647, PMCID: PMC3304301.
Huo C, Yang H, Cui QC, Dou QP, Chan TH. Proteasome inhibition in human breast cancer cells with high
catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs. Bioorg Med Chem. 2010;
(3): 1252-8. doi: 10.1016/j.bmc.2009.12.034. PMID: 20045338, PMCID: PMC2819655.
Zhang Y, Han G, Fan B, Zhou Y, Zhou X, Wei L, et al. Green tea (−)-epigallocatechin-3-gallate downregulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1
activity. European journal of pharmacology. 2009; 606(1-3): 172-9. doi: 10.1016/j.ejphar.2008.12.033.
PMID: 19171136.
Shrubsole MJ, Lu W, Chen Z, Shu XO, Zheng Y, Dai Q, et al. Drinking green tea modestly reduces breast
cancer risk. J Nutr. 2009; 139(2): 310-6. doi: 10.3945/jn.108.098699. PMID: 19074205, PMCID:
PMC2646205.
Zhang M, Huang J, Xie X, Holman CD. Dietary intakes of mushrooms and green tea combine to reduce the
risk of breast cancer in Chinese women. Int J Cancer. 2009; 124(6): 1404-8. doi: 10.1002/ijc.24047. PMID:
Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh WP, Yu MC. Green tea intake, MTHFR/TYMS
genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis. 2008; 29(10): 1967- 72. doi: 10.1093/carcin/bgn177. PMID: 18669903, PMCID: PMC2574755.
Yiannakopoulou ECh. Effect of green tea catechins on breast carcinogenesis: a systematic review of in- vitro and in-vivo experimental studies. Eur J Cancer Prev. 2014; 23(2): 84-9. doi:
1097/CEJ.0b013e328364f23e. PMID: 23939462.
Wu Y, Zhang D, Kang S. Black tea, green tea and risk of breast cancer: an update. Springerplus. 2013;
(1): 240. doi: 10.1186/2193-1801-2-240. PMID: 23750333, PMCID: PMC3671100.
Gu JW, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, et al. EGCG, a major green tea catechin
suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and
VEGF expression. Vasc Cell. 2013; 5(1): 9. doi: 10.1186/2045-824X-5-9. PMID: 23638734, PMCID:
PMC3649947.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
